Ken Moseley, Senior VP and General Counsel at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 15,000 shares at $13.00 ($195K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Scheduled sale ($195k) by Senior VP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BLCM | SELL | 2016-09-20 | $70K | — | Filing → |
| BLCM | SELL | 2016-08-17 | $20K | — | Filing → |
| BLCM | SELL | 2016-06-06 | $195K | — | Filing → |